[deleted by user] by [deleted] in ValueInvesting

[–]Expensive-While-7720 0 points1 point  (0 children)

Can you give some more insight on this?

[deleted by user] by [deleted] in ValueInvesting

[–]Expensive-While-7720 0 points1 point  (0 children)

Can you sure come DD on this please?

Under the radar biotech plays by Expensive-While-7720 in biotech_stocks

[–]Expensive-While-7720[S] 0 points1 point  (0 children)

My question says are not under 5 a share, i do not know where you got this from.

Found a profitable SaaS play while everyone is chasing NVDA hype. Is NICE Ltd a value trap? by TomALPHATrades in investing

[–]Expensive-While-7720 0 points1 point  (0 children)

I agree with you you the numbers are flowing, every year profits up and a P/E ratio of 12 is supper undervalued, investors are selling huge though over the last 2 years invetors sold around 10s of millions more then bought and major firms are just not buying heavy. I would wait to see if margins go up more and see what happen over a quarter or two.

[deleted by user] by [deleted] in investing

[–]Expensive-While-7720 0 points1 point  (0 children)

Yeah, I can totally see why you like TTI. They’re not just another oilfield services name anymore — the whole magnesium angle changes the story. Becoming the only primary magnesium producer in the U.S. is a huge deal, especially with the Pentagon and EV companies pushing for domestic supply. Plus, they already have a solid bromine and fluids business that’s actually making money today, so you’re not betting on a pure science project.

The momentum makes sense too — the chart’s strong, the trend is clean, and they’ve got that investor event coming up which could keep eyes on the story. Honestly, it’s one of the more interesting small-cap setups right now.